Author:
Chen Jing Voon,Higle Julia L.
Publisher
Springer International Publishing
Reference29 articles.
1. American Cancer Society (2017) Cancer facts & figures 2017. American Cancer Society, Atlanta
2. Anderson GL, McIntosh M, Wu L, Barnett M, Goodman G, Thorpe JD, Bergan L, Thornquist MD, Scholler N, Kim N et al (2010) Assessing lead time of selected ovarian cancer biomarkers: a nested case–control study. J Natl Cancer Inst 102(1):26–38
3. Arias E, Heron M, Xu J (2016) United states life tables, 2012. Natl Vital Stat Rep 65(8):14–15
4. Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Saigo PE, Almadrones LA, Barakat RR, Brown CL et al (2000) Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 283(17):2260–2265
5. Brown PO, Palmer C (2009) The preclinical natural history of serous ovarian cancer: defining the target for early detection. PLoS Med 6(7):1–14